The World Health Organisation (WHO) has revealed that Nigeria has expressed interest to be part of the global solidarity drug trial to combat COVID-19. The WHO launched solidarity drug trials for these specific drugs hydroxychloroquine, chloroquine phosphate, and remdesivir in April, Daily Trust reports.
Speaking at the joint national briefing of the presidential task force (PTF) on COVID-19, Fiona Braka, the officer in charge, WHO Nigeria, said efforts are underway to start the process in the country. She said more than 100 countries have joined the solidarity clinical trial, which was launched by WHO and some partners, to help find an effective treatment for COVID-19.
She said over 1,200 patients have been randomized from the first five countries to evaluate the “safety and efficacy of drug combinations”. Braka also said a total of 89 vaccines are being developed globally, including seven in clinical evaluation and several therapeutics in clinical trials.
220 new cases of #COVID19;
— NCDC (@NCDCgov) May 2, 2020
62-Lagos
52-FCT
31-Kaduna
13-Sokoto
10-Kebbi
9-Yobe
6-Borno
5-Edo
5-Bauchi
4-Gombe
4-Enugu
4-Oyo
3-Zamfara
2-Nasarawa
2-Osun
2-Ebonyi
2-Kwara
2-Kano
2-Plateau
2388 confirmed cases of #COVID19 in Nigeria
Discharged: 385
Deaths: 85 pic.twitter.com/06ZsNqpWU8
| Posted: at | |
TRENDING GISTS 
I'm No Longer Interested, My Spirit Has Left There - Fubara Speaks on Returning As Rivers Gov. (VID)
FCT Minister, Nyesom Wike Storms Venue of PDP Meeting With Governors Present
Panic In Abuja As Pastor Shoots Two Immigration Officers After Being Mistaken Them For Robbers
Retired Teacher, Mallam Kabiru Killed, Wife Abducted As Bandits Invade Zamfara School Quarters
Army Busts Gunrunning Syndicate in Plateau, Two Arrested With AK-47 (Photos)
Ringside Rumble? Fans Hype Possible Boxing Showdown Between Small Doctor And Portable